Basics |
Atyr Pharma, Inc.
|
IPO Date: |
May 12, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$501.09M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.11 | 3.48%
|
Avg Daily Range (30 D): |
$0.19 | 3.41%
|
Avg Daily Range (90 D): |
$0.16 | 3.95%
|
Institutional Daily Volume |
Avg Daily Volume: |
.13M |
Avg Daily Volume (30 D): |
3.66M |
Avg Daily Volume (90 D): |
2.24M |
Trade Size |
Avg Trade Size (Sh.): |
167 |
Avg Trade Size (Sh.) (30 D): |
173 |
Avg Trade Size (Sh.) (90 D): |
163 |
Institutional Trades |
Total Inst.Trades: |
64 |
Avg Inst. Trade: |
$2.2M |
Avg Inst. Trade (30 D): |
$2.41M |
Avg Inst. Trade (90 D): |
$2.14M |
Avg Inst. Trade Volume: |
.55M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.51M |
Avg Closing Trade (30 D): |
$2.96M |
Avg Closing Trade (90 D): |
$2.62M |
Avg Closing Volume: |
502.64K |
|
|
Financials |
|
TTM |
FY 2024 |
Q3 2024 |
Basic EPS
|
$-.17
|
$-.86
|
$-.23
|
Diluted EPS
|
$-.17
|
$-.86
|
$-.23
|
Revenue
|
$ M
|
$ .24M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.88M
|
$ -64.02M
|
$ -17.26M
|
Operating Income / Loss
|
$ -15.77M
|
$ -67.91M
|
$ -18.14M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.21M
|
$ -12.02M
|
$ 4.68M
|
PE Ratio
|
|
|
|
|
|
|